GMED - Globus Medical, Inc.
NYSE
->
Healthcare
->
Medical Devices
Audubon,
United States
Type: Equity
GMED price evolution
GMED
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $410.42 | $354.06 | $467.29 | |
| Short term investments | $82.51 | $80.41 | $50.5 | |
| Net receivables | $593.2 | $611.78 | $534.33 | $503.24 |
| Inventory | $717.7 | $770.46 | $816.2 | $848.13 |
| Total current assets | $2056.53 | $1923.89 | $1828.57 | $1915.37 |
| Long term investments | $27.8 | $51.26 | $75.43 | |
| Property, plant & equipment | $622.33 | $625.66 | $635.23 | $646.86 |
| Goodwill & intangible assets | $2320.68 | $2339.31 | $2359.14 | |
| Total noncurrent assets | $3069.9 | $3115.04 | $3170.71 | |
| Total investments | $110.3 | $131.66 | $125.92 | |
| Total assets | $5086.04 | $4993.79 | $4943.61 | $5086.08 |
| Current liabilities | ||||
| Accounts payable | $57.54 | $67.16 | $50.74 | $56.67 |
| Deferred revenue | $19.84 | $17.08 | $18.37 | |
| Short long term debt | $441.6 | $435.79 | $11.97 | |
| Total current liabilities | $818.07 | $794.15 | $786.32 | $392.35 |
| Long term debt | $0.71 | $87.7 | $89.81 | $508.44 |
| Total noncurrent liabilities | $223.28 | $234.93 | $695.78 | |
| Total debt | $529.3 | $525.6 | $520.4 | |
| Total liabilities | $1016.65 | $1017.43 | $1021.25 | $1088.12 |
| Shareholders' equity | ||||
| Retained earnings | $1126.31 | $1074.47 | $1046.84 | $1137.27 |
| Other shareholder equity | -$6.88 | -$11.85 | -$11.04 | -$10.19 |
| Total shareholder equity | $3976.36 | $3922.36 | $3997.96 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $467.29 | $150.47 | $193.07 | $239.4 |
| Short term investments | $50.5 | $295.59 | $250.38 | $187.34 |
| Net receivables | $503.24 | $217.31 | $164.44 | $141.68 |
| Inventory | $848.13 | $298.98 | $237 | $229.15 |
| Total current assets | $1915.37 | $983.34 | $864.52 | $821.76 |
| Long term investments | $75.43 | $495.85 | $562.48 | $358.52 |
| Property, plant & equipment | $646.86 | $243.73 | $221.08 | $216.88 |
| Goodwill & intangible assets | $2359.14 | $261.05 | $248.37 | $243.66 |
| Total noncurrent assets | $3170.71 | $1092.78 | $1092.75 | $857.72 |
| Total investments | $125.92 | $791.44 | $812.85 | $545.87 |
| Total assets | $5086.08 | $2076.13 | $1957.26 | $1679.48 |
| Current liabilities | ||||
| Accounts payable | $56.67 | $36.1 | $24.16 | $27.45 |
| Deferred revenue | $18.37 | $14.1 | $12.03 | $8.13 |
| Short long term debt | $11.97 | |||
| Total current liabilities | $392.35 | $159.2 | $140.16 | $120.79 |
| Long term debt | $508.44 | |||
| Total noncurrent liabilities | $695.78 | $70.55 | $75.71 | $52.4 |
| Total debt | $520.4 | $4.8 | ||
| Total liabilities | $1088.12 | $229.75 | $215.88 | $173.19 |
| Shareholders' equity | ||||
| Retained earnings | $1137.27 | $1239.95 | $1194.27 | $1045.08 |
| Other shareholder equity | -$10.19 | -$9.54 | -$6.77 | $3.96 |
| Total shareholder equity | $3997.96 | $1846.37 | $1741.39 | $1506.3 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $625.71 | $629.69 | $606.67 | $616.53 |
| Cost of revenue | $260.04 | $241.49 | $265.49 | |
| Gross Profit | $355.19 | $369.65 | $365.18 | $351.05 |
| Operating activities | ||||
| Research & development | $37.7 | $57.27 | $52.25 | |
| Selling, general & administrative | $238.12 | $248.71 | $244.72 | |
| Total operating expenses | $306.19 | $320.03 | $357.18 | $340.93 |
| Operating income | $49.62 | $8 | $10.12 | |
| Income from continuing operations | ||||
| EBIT | $49.92 | -$6.66 | $27.57 | |
| Income tax expense | $5.2 | $15.82 | -$1.44 | $9.96 |
| Interest expense | $9.5 | $2.33 | $1.89 | $2.58 |
| Net income | ||||
| Net income | $51.84 | $31.76 | -$7.12 | $15.03 |
| Income (for common shares) | $31.76 | -$7.12 | $15.03 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1568.48 | $1022.84 | $958.1 | $789.04 |
| Cost of revenue | $548.17 | $263.73 | $239.22 | $217.46 |
| Gross Profit | $1020.3 | $759.12 | $718.88 | $571.58 |
| Operating activities | ||||
| Research & development | $124.01 | $73.02 | $97.35 | $84.52 |
| Selling, general & administrative | $643.41 | $432.12 | $408.15 | $354.76 |
| Total operating expenses | $887.16 | $531.17 | $546.93 | $460.15 |
| Operating income | $133.14 | $227.95 | $171.95 | $111.43 |
| Income from continuing operations | ||||
| EBIT | $145.26 | $228.79 | $171.11 | $111.95 |
| Income tax expense | $42.52 | $52.85 | $31.22 | $23.61 |
| Interest expense | -$20.13 | -$14.23 | -$9.3 | -$13.95 |
| Net income | ||||
| Net income | $122.87 | $190.17 | $149.19 | $102.28 |
| Income (for common shares) | $122.87 | $190.17 | $149.19 | $102.28 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $31.76 | -$7.12 | $15.03 | |
| Operating activities | ||||
| Depreciation | $63.59 | $55.26 | $71.16 | |
| Business acquisitions & disposals | -$4.89 | -$12.65 | ||
| Stock-based compensation | $12.81 | $17.26 | $12.45 | |
| Total cash flows from operations | $54.26 | $52.39 | $104.67 | |
| Investing activities | ||||
| Capital expenditures | -$27.8 | -$28.57 | -$22.88 | |
| Investments | $22.31 | -$5.37 | $343.5 | |
| Total cash flows from investing | -$71.93 | -$10.38 | -$46.58 | $320.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $12.77 | -$79.9 | -$224.52 | |
| Net borrowings | ||||
| Total cash flows from financing | -$87.43 | $8.71 | -$115.72 | -$237.27 |
| Effect of exchange rate | $4.53 | $3.77 | -$3.31 | -$0.35 |
| Change in cash and equivalents | $155.47 | $56.36 | -$113.23 | $187.67 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $122.87 | $190.17 | $149.19 | $102.28 |
| Operating activities | ||||
| Depreciation | $144.73 | $68.25 | $69.87 | $62.87 |
| Business acquisitions & disposals | -$296.03 | -$31.43 | -$34.49 | -$33.48 |
| Stock-based compensation | $52.74 | $32.81 | $30.59 | $27.07 |
| Total cash flows from operations | $243.5 | $178.47 | $276.27 | $198.79 |
| Investing activities | ||||
| Capital expenditures | -$78.27 | -$74.05 | -$56.9 | -$63.66 |
| Investments | $677.27 | -$4.88 | -$284.55 | -$20.18 |
| Total cash flows from investing | $302.97 | -$110.36 | -$375.94 | -$117.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$213.16 | -$102.78 | $63.5 | -$32.35 |
| Net borrowings | ||||
| Total cash flows from financing | -$231.82 | -$109.96 | $54.15 | -$38.66 |
| Effect of exchange rate | $2.18 | -$0.75 | -$0.81 | $0.86 |
| Change in cash and equivalents | $316.83 | -$42.6 | -$46.33 | $43.67 |
News
Fundamentals
| Market cap | $10.91B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 135.90M |
| Revenue | $2.48B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $91.51M |
| Revenue Q/Q | 63.10% |
| Revenue Y/Y | 102.10% |
| P/E ratio | 119.22 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.40 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.67 |
|---|---|
| ROA | 1.82% |
| ROE | N/A |
| Debt/Equity | 0.27 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.51 |
| Quick ratio | 1.64 |